US Patent 7399771 Piperidine derivatives as CCR5 inhibitors

Patent 7399771 was granted and assigned to Novartis on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73997710

Patent Inventor Names

Rainer Albert0

Hans-Günter Zerwes0

Markus Streiff0

Nigel Graham Cooke0

Christian Bruns0

François Nuninger0

Gebhard Thoma0

Date of Patent

July 15, 2008

Patent Application Number

105297760

Date Filed

October 6, 2003

Patent Primary Examiner

‌

Celia Chang

Patent abstract

Disclosed are compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7399771 Piperidine derivatives as CCR5 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API